🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Vasudevan Lab makes its first twitter post: Excited to share our preprint looking at functional interactions between NF tumor suppressors assets.researchsquare.com/files/rs-19337…

Big congratulations to Lexi Haugh on her ASCO YIA! Excited to make some progress on (NF1 mutant) metastatic melanoma

So pleased to see our work in Nature Communications, led by Anna Skakodub, Henry Walch, and Kathryn Ries Tringale, with Niki Schultz, describing the genomics and clinical outcomes of a large set of patients with NSCLC brain metastasis. Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Radiation Oncology rdcu.be/djJ2f

Our manuscript investigating bulk and single cell genomics of melanoma brain metastases is now online! Many thanks to everyone that made this work possible jamanetwork.com/journals/jaman…

Looking forward to #SNO2023 presentation by #FrancisSCollinsScholar Vasudevan Lab presenting innovative approaches to targeting NF1 loss in nervous system tumors SNO @NTAPresearch Johns Hopkins Medicine #NF

Delighted to share that our work looking at functional interactions between neurofibromatosis tumor suppressors is officially accepted: rdcu.be/dvPyh

Very proud of Lexi Haugh for her analysis of targeted DNA sequencing in cutaneous melanoma: biorxiv.org/content/10.110… Adil Daud

New featured image on our homepage! nature.com/ncomms/ 3 papers on schwannomas, tumors of the nervous system derived from Schwann cells Vasudevan Lab RaleighLab John Liu, MD PhD #CancerResearch Cancer at Nature Portfolio nature.com/articles/s4146… nature.com/articles/s4146… nature.com/articles/s4146…

Additionally, in a study led by Vasudevan Lab & RaleighLab, researchers demonstrate how NF-1 mutant Schwann cell tumors undergo malignant transformation, identifying new potential strategies against treatment resistance: nature.com/articles/s4146… UCSF Helen Diller Family Comprehensive Cancer Ctr #neurofibromatosis

A pleasure to review the therapeutic landscape for NF-1 with my future colleague @bnamd87 rdcu.be/dG8Lq

Excited that our DoD New Investigator Award (cdmrp.health.mil/nfrp/awards/23…) is officially funded - thanks to everyone that helped make this happen CDMRP Dominic Esposito Simanshu Dhirendra and time to get to work!

Sunrise-ish run through brussels - enjoying every part of the annual Children's Tumor Fdn meeting #nfcon24 with friends from UCSF Neurosurgery Neurofibromatosis Therapeutic Acceleration Program

A delightful time catching up with 10 of NTAP’s 18 Francis S. Collins Scholars & their mentors while in Brussels Children's Tumor Fdn. Thank you all for your dedication to moving the needle in NF1 research! #NFCON24 #endNF

Happy 4th of July - to celebrate, we asked if there is meaningful heterogeneity within somatic NF1 mutant glioblastomas? We think so biorxiv.org/content/10.110… As always, appreciate everyone that made this work possible UCSF Neurosurgery UCSF Helen Diller Family Comprehensive Cancer Ctr Neurofibromatosis Therapeutic Acceleration Program Children's Tumor Fdn

Excellent time giving grand rounds last week U-M Rogel Cancer Center with old friends goutham narla and new ones maria g castro UCSF Helen Diller Family Comprehensive Cancer Ctr UCSF Neurosurgery